Quantitative immunocytochemical assays of topoisomerase II in lung adenocarcinoma cell lines - correlation to topoisomerase IIα content and topoisomerase II catalytic activity

被引：0
|
作者：
Yamazaki, K.
Isobe, H.
Hanada, T.
Sukoh, N.
Ogura, S.
Kawakami, Y.
机构：
来源：
Acta Oncologica | / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Quantitative immunocytochemical assays of topoisomerase II in lung adenocarcinoma cell lines - Correlation to topoisomerase II alpha content and topoisomerase II catalytic activity
    Yamazaki, K
    Isobe, H
    Hanada, T
    Sukoh, N
    Ogura, S
    Kawakami, Y
    ACTA ONCOLOGICA, 1996, 35 (04) : 417 - 423
  • [2] Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines
    Yamazaki, K
    Isobe, H
    Hanada, T
    Betsuyaku, T
    Hasegawa, A
    Hizawa, N
    Ogura, S
    Kawakami, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (03) : 192 - 198
  • [3] Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage
    Gieseler, F
    Bauer, E
    Nuessler, V
    Clark, M
    Valsamas, S
    LEUKEMIA, 1999, 13 (11) : 1859 - 1863
  • [4] Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage
    F Gieseler
    E Bauer
    V Nuessler
    M Clark
    S Valsamas
    Leukemia, 1999, 13 : 1859 - 1863
  • [5] Relationship between topoisomerase II levels and resistance to topoisomerase II inhibitors in lung cancer cell lines
    Houlbrook, S
    Harris, AL
    Carmichael, J
    Stratford, IJ
    ANTICANCER RESEARCH, 1996, 16 (4A) : 1603 - 1610
  • [6] Enhanced topoisomerase I activity and increased topoisomerase IIα content in cisplatin-resistant cancer cell lines
    Minagawa, Y
    Kigawa, J
    Irie, T
    Kanamori, Y
    Itamochi, H
    Cheng, XS
    Terakawa, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (12): : 1218 - 1223
  • [7] Catalytic inhibitors of DNA topoisomerase II
    Andoh, T
    Ishida, R
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 155 - 171
  • [8] Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity
    Ganapathi, Mahrukh K.
    Grozav, Adrian G.
    Willard, Belinda B.
    Kozuki, Toshiyuki
    Chikamori, Kenichi
    Micluta, Marius A.
    Petrescu, Andrei-Jose
    Kinter, Michael
    Ganapathi, Ram N.
    CANCER RESEARCH, 2011, 71
  • [9] Bisdioxopiperazine topoisomerase II catalytic inhibitors as agents to target the toxicity of topoisomerase II poisons to tumours.
    Jensen, PB
    Sehested, M
    CLINICAL CANCER RESEARCH, 1999, 5 : 3864S - 3864S
  • [10] DNA topoisomerase I, DNA topoisomerase IIα, and DNA topoisomerase IIβ as markers for human tumors.
    Foglesong, PD
    Reyes, A
    Breitenstein, H
    Martin, L
    D'Andrea, MR
    Connolly, RT
    Szcykalski, LM
    FASEB JOURNAL, 1998, 12 (04): : A197 - A197
12345